Prot #OPT-302-1005: A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Aflibercept, Compared with Aflibercept Alone, in Participants with Neovascular Age-related Macular

Project: Research project

Project Details

StatusFinished
Effective start/end date9/22/21 → 4/30/25

Funding

  • Quintiles, Inc. ((OE) Prot #OPT-302-1005 // (OE) Prot #OPT-302-1005)
  • Opthea Limited ((OE) Prot #OPT-302-1005 // (OE) Prot #OPT-302-1005)